Towards Healthcare
Spinal Cord Injury Treatment Market Surges USD 11.94 Bn by 2034

Spinal Cord Injury Treatment Market Key Players, Technologies and Future Trends

Based on market forecasts, the spinal cord injury treatment sector will expand from USD 7.47 billion in 2024 to USD 11.94 billion by 2034, experiencing a CAGR of 4.8%. In 2023, complete spinal cord injuries led the market with a 60% share, while corticosteroids held 40%. Hospitals were the top providers, also with 60% market share. Key players in the spinal cord injury treatment market included Acorda Therapeutics, Novartis, Pfizer, InVivo Therapeutics, and BioArctic AB.

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Spinal Cord Injury Treatment Market Assessment

  • Overview
  • Global Spinal Cord Injury Treatment Market Size Value (US$) and Volume (Billion Tons), by Injury Type (2021 – 2033)
    • Complete Spinal Cord Injuries
    • Partial Spinal Cord Injuries
  • Global Spinal Cord Injury Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
    • Corticosteroid
    • Surgery
    • Spinal Traction
    • Others
  • Global Spinal Cord Injury Treatment Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospital
    • Trauma Centers
    • Ambulatory Surgical Centers
    • Others
  • Global Spinal Cord Injury Treatment Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia Pacific
    • Middle East and Africa
    • South America

North America Spinal Cord Injury Treatment Market Assessment

  • Overview
  • North America Spinal Cord Injury Treatment Market Size Value (US$) and Volume (Billion Tons), by Injury Type (2021 – 2033)
    • Complete Spinal Cord Injuries
    • Partial Spinal Cord Injuries
  • North America Spinal Cord Injury Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
    • Corticosteroid
    • Surgery
    • Spinal Traction
    • Others
  • North America Spinal Cord Injury Treatment Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospital
    • Trauma Centers
    • Ambulatory Surgical Centers
    • Others

Europe Spinal Cord Injury Treatment Market Assessment

  • Overview
  • Europe Spinal Cord Injury Treatment Market Size Value (US$) and Volume (Billion Tons), by Injury Type (2021 – 2033)
    • Complete Spinal Cord Injuries
    • Partial Spinal Cord Injuries
  • Europe Spinal Cord Injury Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
    • Corticosteroid
    • Surgery
    • Spinal Traction
    • Others
  • Europe Spinal Cord Injury Treatment Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospital
    • Trauma Centers
    • Ambulatory Surgical Centers
    • Others

Asia Pacific Spinal Cord Injury Treatment Market Assessment

  • Overview
  • Asia Pacific Spinal Cord Injury Treatment Market Size Value (US$) and Volume (Billion Tons), by Injury Type (2021 – 2033)
    • Complete Spinal Cord Injuries
    • Partial Spinal Cord Injuries
  • Asia Pacific Spinal Cord Injury Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
    • Corticosteroid
    • Surgery
    • Spinal Traction
    • Others
  • Asia Pacific Spinal Cord Injury Treatment Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospital
    • Trauma Centers
    • Ambulatory Surgical Centers
    • Others

Middle East and Africa Spinal Cord Injury Treatment Market Assessment

  • Overview
  • Middle East and Africa Spinal Cord Injury Treatment Market Size Value (US$) and Volume (Billion Tons), by Injury Type (2021 – 2033)
    • Complete Spinal Cord Injuries
    • Partial Spinal Cord Injuries
  • Middle East and Africa Spinal Cord Injury Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
    • Corticosteroid
    • Surgery
    • Spinal Traction
    • Others
  • Middle East and Africa Spinal Cord Injury Treatment Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospital
    • Trauma Centers
    • Ambulatory Surgical Centers
    • Others

South America Spinal Cord Injury Treatment Market Assessment

  • Overview
  • South America Spinal Cord Injury Treatment Market Size Value (US$) and Volume (Billion Tons), by Injury Type (2021 – 2033)
    • Complete Spinal Cord Injuries
    • Partial Spinal Cord Injuries
  • South America Spinal Cord Injury Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
    • Corticosteroid
    • Surgery
    • Spinal Traction
    • Others
  • South America Spinal Cord Injury Treatment Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospital
    • Trauma Centers
    • Ambulatory Surgical Centers
    • Others

Company Profiles

  • Acorda Therapeutics, Inc.
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Asterias Biotherapeutics
  • ReNetX Bio.
  • BioArctic AB
  • BioTime, Inc.
  • InVivo Therapeutics
  • Kringle Pharma, Inc.
  • Novartis AG
  • Pfizer Inc.
  • Pharmicell Co. Ltd.

Conclusion & Recommendations

  • Insight Code: 5143
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: May 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

Symptoms of spinal cord injury may include loss of sensation or movement, difficulty breathing, muscle weakness, and loss of bowel or bladder control.

The driving factors affecting the spinal cord injury treatment market include demographic shifts such as aging populations, and ongoing innovations in medical technology and rehabilitation techniques.

The hurdles of the spinal cord injury treatment market include limited treatment options, financial constraints, and the complexity of regenerating nerve tissue.

World Health Organization, Food and Drug Administration, National Institute of Health, MedlinePlus.gov and Treasury.gov.au.